Impedimed Ltd has released a press release.
Appendix 4E
Filed with ASX ·
On 6ix: 6ix.com/news/appendix-4e-116
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Earlier from Impedimed
- Quarterly Activities Report and Appendix 4C - Jun-2025 Qtr
- Q4 FY25 sales and growth capital facility update
- Quarterly Activities Report and Appendix 4C - Mar-2025 Qtr
- S&P DJI Announces March 2025 Quarterly Rebalance
- ImpediMed secures US$15 million growth capital facility
Later from Impedimed
- Major US health insurer publishes positive coverage
- Quarterly Activities Report and Appendix 4C - Sep-2025 Qtr
- Quarterly Activities Report and Appendix 4C - Dec-2025
- ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors
- Appendix 4D and Interim Financial Report
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed